[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357555-105":59,"doc-detail-357555-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","artificial-intelligence-integrated-multi-omics-and-multimodal-studies-promote-the-efficacy-of-neoadjuvant-chemotherapy-in-breast-cancer-opportunities-challenges-and-future-perspectives","Artificial intelligence integrated multi-omics and multimodal studies promote the efficacy of neoadjuvant chemotherapy in breast cancer: opportunities, challenges, and future perspectives","","Neoadjuvant chemotherapy (NAC) is a key strategy for locally advanced breast cancer, yet its clinical value is limited by tumor heterogeneity and insufficient reliable predictive biomarkers. This review explains how integrating single-omics, multimodal, and multi-omics technologies enables a more complete view of tumor biology, while artificial intelligence supports efficient interpretation of high-dimensional data. It summarizes AI roles in treatment-response prediction, biomarker discovery, and profiling immune and molecular features, and outlines key challenges in data quality, interpretability, ethics, and clinical translation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/artificial-intelligence-integrated-multi-omics-and-multimodal-studies-promote-the-efficacy-of-neoadjuvant-chemotherapy-in-breast-cancer-opportunities-challenges-and-future-perspectives/357555/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/artificial-intelligence-integrated-multi-omics-and-multimodal-studies-promote-the-efficacy-of-neoadjuvant-chemotherapy-in-breast-cancer-opportunities-challenges-and-future-perspectives/357555.png","ImageObject",300,407,{"name":92,"@type":93},"Guten tag","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is neoadjuvant chemotherapy important in breast cancer, and what limits its current clinical utility?","Question",{"text":112,"@type":113},"NAC is used for locally advanced or high-risk early-stage breast cancer, but its utility is constrained by tumor heterogeneity and the lack of reliable predictive biomarkers, which limits accurate treatment-response prediction.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does integrating single-omics, multimodal, and multi-omics data help in NAC research?",{"text":117,"@type":113},"These integrations provide comprehensive, complementary insights into tumor biology by combining different biological layers and data types, while AI enables efficient integration and interpretation of high-dimensional datasets.",{"name":119,"@type":110,"acceptedAnswer":120},"What are the main challenges for AI-empowered multi-omics studies before clinical translation?",{"text":121,"@type":113},"Key challenges include data quality, model interpretability, ethical concerns, and the difficulties of translating AI methods into clinical practice, which often require better data-sharing architectures and interdisciplinary collaboration.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},357555,1790219692,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","Ye etal. Breast Cancer Research (2026) 28:127 Breast Cancer Research  \n[https://doi.org/10.1186/s13058-026-02303-x](https://doi.org/10.1186/s13058-026-02303-x)  \nREVIEW Open Access  \nArtificial intelligence integrated multi-omics and multimodal studies promote the efficacy of neoadjuvant chemotherapy in breast  \ncancer: opportunities, challenges, and future perspectives  \nSijing Ye1,2, Zimeng Jin1,2, Wenjing Li1,2, Guikang Wei1,2, Shiying Jiang1,2 and Qinchuan Wang1,2*  \nAbstract  \nBackground Neoadjuvant chemotherapy (NAC) is a critical therapeutic strategy for locally advanced breast cancer; however, its clinical utility is constrained by tumor heterogeneity and a lack of reliable predictive biomarkers. Integrating single-omics, multimodal, and multi-omics technologies provides comprehensive insights into the tumor biology, while artificial intelligence (AI) facilitates the efficient integration and interpretation of these highdimensional data.  \nMain body Based on a comprehensive literature search, we review and synthesize existing literature on the progress of AI-driven data integration in the NAC of breast cancer. We highlight the significant role of AI in predicting treatment response, discovering biomarkers, and profiling tumor heterogeneity and immune microenvironment. We also discussed the major challenges, including data quality, model interpretability, ethical concerns, and clinical translation in AI-empowered multi-omics studies. Moreover, recent advances in spatial multi-omics and large language models to decode intratumoral heterogeneity and to support clinical decision were also discussed. However, despite these significant progressions, translation of these innovations into practice still requires data-sharing architectures and interdisciplinary collaboration.  \nConclusions AI empowered data integration holds profound potential to decode the complex molecular landscape of breast cancer, which will ultimately promote precise personalized NAC strategies and prognosis of patients. Highlights  \n• AI integrates single-omics, multimodal, and multi-omics data to improve response prediction, biomarker discovery, and tumor profiling in breast cancer NAC.  \n• However, the implementation of these technologies faces critical challenges regarding data quality, model interpretability, ethical regulation, and clinical translation.  \n*Correspondence: Qinchuan Wang [wangqinchuan@zju.edu.cn](wangqinchuan@zju.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nYe et al. Breast Cancer Research (2026) 28:127 Page 2 of 16  \n• Future breakthroughs rely on spatial multi-omics to decode intratumoral heterogeneity and large language models (LLMs) to support precision oncology.  \nKeywords Breast cancer, Artificial intelligence, Neoadjuvant chemotherapy, Multi-omics, Multi-modal  \nIntr","cbCaijzaGFiHsrsX","https://ap.wps.com/l/cbCaijzaGFiHsrsX","pdf",1655393,16,"English","# Abstract\n# Introduction\n## Clinical importance of NAC and current limitations\n## Need for better biomarkers and predictive tools\n## Single-omics, multimodal integration, and multi-omics approaches\n# Main body\n## AI-driven data integration: response prediction and biomarker discovery\n## Challenges: data quality, interpretability, ethics, translation\n## Future directions: spatial multi-omics and large language models\n# Conclusions\n# Highlights","[{\"question\":\"Why is neoadjuvant chemotherapy important in breast cancer, and what limits its current clinical utility?\",\"answer\":\"NAC is used for locally advanced or high-risk early-stage breast cancer, but its utility is constrained by tumor heterogeneity and the lack of reliable predictive biomarkers, which limits accurate treatment-response prediction.\"},{\"question\":\"How does integrating single-omics, multimodal, and multi-omics data help in NAC research?\",\"answer\":\"These integrations provide comprehensive, complementary insights into tumor biology by combining different biological layers and data types, while AI enables efficient integration and interpretation of high-dimensional datasets.\"},{\"question\":\"What are the main challenges for AI-empowered multi-omics studies before clinical translation?\",\"answer\":\"Key challenges include data quality, model interpretability, ethical concerns, and the difficulties of translating AI methods into clinical practice, which often require better data-sharing architectures and interdisciplinary collaboration.\"}]","Artificial intelligence integrated multi-omics and multimodal studies promote the efficacy of neoadjuvant chemotherapy in breast cancer: opportunities, challenges, and future perspectives | PDF",1790130373,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/821a5f76d6496ef722b76f766b962ccc.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5204ddacf92f2771097402cb30864aab.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26360caec1a8ead8336e4d3eb4b7eb5a.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8fae4e14e7e928ae2d834cf0f67c19d4.webp",980,1306]